Tadalafil
- PMID: 14498756
- DOI: 10.2165/00003495-200363200-00004
Tadalafil
Erratum in
- Drugs. 2003;63(23):2703
Abstract
black triangle Tadalafil is a selective phosphodiesterase type 5 inhibitor that is effective in men with mild-to-severe erectile dysfunction (ED), including those with diabetes mellitus. black triangle The improvement in the erectile function domain score on the International Index of Erectile Function (IIEF) and the percentage of sexual intercourse attempts marked by successful vaginal penetration and completion was significantly greater with on-demand (not more than once daily) tadalafil 10 or 20 mg than placebo in trials of 12 weeks' duration. Improvement in scores on other domains of the IIEF and the percentage of positive responses to a Global Assessment Question measuring erection improvement were also significantly greater with on-demand tadalafil than placebo. black triangle The adverse events associated with tadalafil were generally mild to moderate and decreased in frequency with continued administration. The most commonly reported adverse events were headache and dyspepsia. The incidence of cardiovascular adverse events was not significantly different in tadalafil or placebo recipients.
Similar articles
-
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.BJU Int. 2004 Oct;94(6):871-7. doi: 10.1111/j.1464-410X.2004.05049.x. BJU Int. 2004. PMID: 15476525 Clinical Trial.
-
Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil.J Sex Med. 2004 Nov;1(3):292-300. doi: 10.1111/j.1743-6109.04042.x. J Sex Med. 2004. PMID: 16422959 Clinical Trial.
-
The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.J Urol. 2004 Aug;172(2):652-7. doi: 10.1097/01.ju.0000132857.39680.ce. J Urol. 2004. PMID: 15247754 Clinical Trial.
-
Vardenafil: a review of its use in erectile dysfunction.Drugs. 2003;63(23):2673-703. doi: 10.2165/00003495-200363230-00010. Drugs. 2003. PMID: 14636086 Review.
-
Phosphodiesterase 5 inhibitors for erectile dysfunction.Ann Pharmacother. 2005 Jul-Aug;39(7-8):1286-95. doi: 10.1345/aph.1E487. Epub 2005 Jun 7. Ann Pharmacother. 2005. PMID: 15941818 Review.
Cited by
-
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.Br J Clin Pharmacol. 2007 Jan;63(1):24-35. doi: 10.1111/j.1365-2125.2006.02726.x. Epub 2006 Jul 21. Br J Clin Pharmacol. 2007. PMID: 16869816 Free PMC article.
-
Selecting an Individualized Treatment Approach: The Predictive Value of Erotic Stimulation and Nocturnal Erections for Efficacy of Tadalafil and Cure in Patients With Erectile Dysfunction.Front Endocrinol (Lausanne). 2022 Jun 29;13:915025. doi: 10.3389/fendo.2022.915025. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846318 Free PMC article.
-
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.Front Pharmacol. 2012 Sep 18;3:167. doi: 10.3389/fphar.2012.00167. eCollection 2012. Front Pharmacol. 2012. PMID: 23024633 Free PMC article.
-
Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile.Molecules. 2021 Feb 3;26(4):794. doi: 10.3390/molecules26040794. Molecules. 2021. PMID: 33546456 Free PMC article.
-
Efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand tadalafil for erectile dysfunction.Arab J Urol. 2022 Jun 24;20(4):189-194. doi: 10.1080/2090598X.2022.2090134. eCollection 2022. Arab J Urol. 2022. PMID: 36353469 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical